Can AbbVie Regain Its Status As a Top Dividend Growth Stock?

By Yahoo! Finance | Sep 16, 2024 at 07:06 AM EST

AbbVie, known for its strong dividend growth, faces challenges post-Humira patent expiration. Despite slower dividend growth, its pipeline and acquisitions offer hope for recovery. Investors should monitor its financial health indicators for future dividend growth potential.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.